Offer : pcd pharma franchise , third party manufacturing
ACTIPRAZ-LXR :
Esomeprasole magnisium trihydrate IP40mg (As enteric coated pellets ) + Levosulpride 75 mg (As sustained release pellets) Capsules.
INDICATION :
*GERD
*Hyperacidity with Diabetic Gastroparesis
*Peptic & Duodenal Ulcers
*Other Dysmotility Conditions
Esomeprazole:
* The fastest acting PPI provides fast onset of action and fast relief.
* Provides 99% inhibition of proton pump.
* Ensures complete relief from the symptoms with complete inhibition on acid release.
Levosulpiride :
* The new prokinetic agent , demonstrates greater central antidopaminerdgic activity, antiseptic & antidyspectic effects
* Significantly reduces gastric emptying time.
*Increases fundic accommodation & increases antral – duodenal motility.
